NEARLY one thousand researchers working on various aspects of myology met this year in Marseille for the 3rd International Congress of myology.
AT the end of this scientific event, we observed advances and openings: new drugs, the arrival of new molecular treatment principles and several action principles are currently progressing into treatment principles. Furthermore, for a therapy principle, other diseases are becoming eligible (eg exon skipping for some dysferlinopathies). 
IT is also clear that the science and clinical practice of myology form a distinct field of medicine, in the same way that neurology became separated from internal medicine over a hundred years ago. This is evident not only because of the increasing knowledge and the arrival of basic researchers and clinicians, but also because of treatments that in themselves create a dynamism favouring the recognition of myology as a discipline in its own right.